WEXFORD CAPITAL LP Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$384.6B

Holdings

217

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (217 positions)

#StockSharesValue% PortfolioType
201
EMBJEMBRAER S.A.
2,162$99.9M0.03%
202
VKTXVIKING THERAPEUTICS INC
4,083$98.6M0.03%
203
FLBSTANDARD BIOTOOLS INC
83,638$90.3M0.02%
204
NAUTNAUTILUS BIOTECHNOLOGY INC
104,580$90.0M0.02%
205
YUMCYUM CHINA HLDGS INC
1,700$88.5M0.02%
206
ADPTADAPTIVE BIOTECHNOLOGIES COR
11,197$83.2M0.02%
207
CRBPCORBUS PHARMACEUTICALS HLDGS
15,400$81.8M0.02%
208
NMRANEUMORA THERAPEUTICS INC.
77,879$77.9M0.02%
209
CDNACAREDX INC
4,374$77.6M0.02%
210
SDGRSCHRODINGER INC
3,902$77.0M0.02%
211
AFWALIGN TECHNOLOGY INC
479$76.1M0.02%
212
PSNLPERSONALIS INC
16,316$57.3M0.01%
213
TUYATUYA INC
13,549$41.0M0.01%
214
CDECOEUR MNG INC
6,343$37.5M0.01%
215
CISSC3IS INC
24,632$16.0M0.00%
216
CCCCC4 THERAPEUTICS INC
7,731$12.4M0.00%
217
IBACRIB ACQUISITION CORP
139,950$10.5M0.00%
PreviousPage 3 of 3